News Releases

February 25, 2015

RESEARCH TRIANGLE PARK, NC— To address the growing challenges of creating adequate security regulations to protect against terrorism, a new book, "Benefit-Cost Analyses for Security Policies," offers an outline for evaluating homeland security policies within the framework of benefit-cost...

February 24, 2015

RTI-HS researcher Emily Reese, PhD, MPH, was invited to speak about budget impact models (BIM) to the University of North Carolina at Chapel Hill ISPOR student chapter. Dr. Reese was the 2012-13 ISPOR Student Network Chair, responsible for providing oversight to ISPOR’s 60 student chapters...

February 17, 2015

The journal for the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) has released its latest collection of research articles delivering insights on economic evaluation and outcomes research, and conceptual, methodological, and health policy pieces. Our Health Preference...

January 29, 2015

RESEARCH TRIANGLE PARK, NC—RTI Health Solutions (RTI-HS), a business unit of RTI International, partnered with the U.S. Food and Drug Administration (FDA) to conduct a study on patients’ preferences which contributed to the Agency’s regulatory decision to approve the Maestro Rechargeable System...

January 26, 2015

Will FDA's patient-centered drug development initiatives increase the prevalence of patient-reported outcomes (PRO) research during early phases of drug development?

January 23, 2015

FDA wants to see patient perspectives on the benefits and risks of a new device when manufacturers seek market approval. But manufacturers don’t always know how to collect and use this data in the regulatory process.

January 20, 2015

Watch the recorded session of our webinar that explores the shift in payer perspectives in response to increased R&D efforts toward orphan products.

January 8, 2015

Jamie Rosenzweig, MD recently joined RTI-HS as Senior Director of Clinical Consulting and our 13th physician on staff. In his role, Rosenzweig serves as an internal consultant for projects that require diabetes, endocrinology, or internal medicine expertise as well as a consultant for our...

January 5, 2015

RESEARCH TRIANGLE PARK, NC— Kati Copley-Merriman, vice president of Market Access and Outcomes Strategy at RTI Health Solutions (RTI-HS), a business unit of RTI International, has been named a member of the Value in Health Editorial Advisory Board. Value in Health, the official journal of the...

December 9, 2014

Dr. Kenneth Rothman, Distinguished Fellow and Vice President of Epidemiology Research, had the honor of giving the 160th Cutter Lecture on Preventive Medicine at the Harvard School of Public Health on December 3rd, 2014.


December 9, 2014

RESEARCH TRIANGLE PARK, N.C. – A new report by researchers at RTI Health Solutions (RTI-HS) and parent company RTI International, found that although healthcare databases have allowed for greater access to real world medical data, using databases to evaluate the safety of medical products is...

December 3, 2014

Over 45 of our scientists and consultants attended the 17th Annual ISPOR European Congress in Amsterdam; below are some of their insights from the conference.

November 14, 2014

RESEARCH TRIANGLE PARK, NC — James (Jamie) Rosenzweig, MD, has joined RTI Health Solutions (RTI-HS), a business unit of RTI International, as senior director of clinical consulting.

October 29, 2014

AMSTERDAM— Researchers from RTI Health Solutions (RTI-HS), a business unit of RTI International, will discuss challenges and solutions for improving European health care at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 17th Annual European Congress in Amsterdam,...

October 17, 2014

Together with colleagues from the University of Glasgow and Biogen Idec, Sorrel Wolowacz, Head of European Health Economics, and Lynda Doward, European Head of Patient-Reported Outcomes, co-authored an...

October 15, 2014

In late September, 2014, the FDA convened a public meeting entitled “Patient-Focused Drug Development for Hemophilia A, Hemophilia B, von Willebrand Disease and other Heritable Bleeding Disorders." Dr.

August 1, 2014

On July 16, 2014, the Engelberg Center for Health Care Reform, in cooperation with the FDA, held an expert workshop that focused on the major issues related to the development and use of Patient-Reported Outcome (PRO) instruments to support...

July 31, 2014

When you choose a pharmaceutical research partner, you want to know the credentials of the team conducting your research and the relevant experience they bring to your project.

July 17, 2014

We are delighted to announce the seven year anniversary of opening our Barcelona, Spain office.  In the summer of 2007, the office was opened with a small, 5-person research team to strengthen our expert base and research network in Europe to meet the growing pharmacoepidemiological activities...

June 30, 2014

Josephine Mauskopf, Ph.D., vice president of Health Economics at RTI Health Solutions, a business unit of RTI International, has been elected to the board of directors of the International Society for Pharmacoeconomics and Outcomes Research. She will serve a two-year term.

June 23, 2014

A new book, with chapters authored by three researchers at RTI Health Solutions, a business unit of RTI International, provides a first-of-its-kind overview of benefit-risk assessment from both the scientific and...

June 16, 2014

RTI-HS staff led and presented 27 posters, several workshops, a sponsored educational symposium, and other sessions at the International Society for Pharmacoeconomics and Outcomes Research Annual Meeting in Montreal, Quebec, Canada, May 31-June 4, 2014. To access our full list of posters and...

May 20, 2014

A new book provides a definitive drug safety resource for pharmaceutical researchers and students. The book brings together 136 experts from around the world who represent all aspects of pharmacovigilance.

March 24, 2014

As long as statins, a class of cholesterol-lowering drugs, remain inexpensive and don’t affect the patient’s quality of life, it is better to simply prescribe the drugs before ordering a heart scan, finds a new study by researchers at University of California at San Francisco; RTI Health...